Evidence map›Paper›PMID 26107379›Full record

ArticlePloS one2015

Intermittent Androgen Suppression: Estimating Parameters for Individual Patients Based on Initial PSA Data in Response to Androgen Deprivation Therapy.

Yoshito Hirata, Kai Morino, Koichiro Akakura, Celestia S Higano, Nicholas Bruchovsky, Teresa Gambol, Susan Hall, Gouhei Tanaka, Kazuyuki Aihara

Abstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yoshito HirataInstitute of Industrial Science, The University of Tokyo, Meguro-ku, Tokyo 153-8505, Japan; Graduate School of Information Science and Technology, The University of Tokyo, Tokyo, Japan.
Kai MorinoGraduate School of Information Science and Technology, The University of Tokyo, Tokyo, Japan.
Koichiro AkakuraDepartment of Urology, JCHO Tokyo Shinjuku Medical Center, Japan Community Health Care Organization Tokyo, Japan.
Celestia S HiganoDepartment of Medicine, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Nicholas BruchovskyVancouver Prostate Centre, Vancouver, BC, Canada.
Teresa GambolDepartment of Medicine, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Susan HallDepartment of Medicine, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Gouhei TanakaInstitute of Industrial Science, The University of Tokyo, Meguro-ku, Tokyo 153-8505, Japan; Graduate School of Information Science and Technology, The University of Tokyo, Tokyo, Japan; Graduate School of Engineering, The University of Tokyo, Tokyo, Japan.
Kazuyuki AiharaInstitute of Industrial Science, The University of Tokyo, Meguro-ku, Tokyo 153-8505, Japan; Graduate School of Information Science and Technology, The University of Tokyo, Tokyo, Japan; Graduate School of Engineering, The University of Tokyo, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

When a physician decides on a treatment and its schedule for a specific patient, information gained from prior patients and experience in the past is taken into account. A more objective way to make such treatment decisions based on actual data would be useful to the clinician. Although there are many mathematical models proposed for various diseases, so far there is no mathematical method that accomplishes optimization of the treatment schedule using the information gained from past patients or "rapid learning" technology. In an attempt to use this approach, we integrate the information gained from patients previously treated with intermittent androgen suppression (IAS) with that from a current patient by first fitting the time courses of clinical data observed from the previously treated patients, then constructing the prior information of the parameter values of the mathematical model, and finally, maximizing the posterior probability for the parameters of the current patient using the prior information. Although we used data from prostate cancer patients, the proposed method is general, and thus can be applied to other diseases once an appropriate mathematical model is established for that disease.

Indexed as

Models, StatisticalAndrogen AntagonistsBayes TheoremBiomarkers, TumorComputer SimulationGene ExpressionHumansMalePrecision MedicineProstate-Specific AntigenProstatic NeoplasmsTestosteroneAndrogen AntagonistsBiomarkers, TumorProstate-Specific AntigenTestosterone

Identifiers

PMID26107379
PMCPMC4481271

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.